S&P 500 Futures
(0.27%) 5 310.00 points
Dow Jones Futures
(0.29%) 38 904 points
Nasdaq Futures
(0.34%) 18 654 points
Oil
(-0.06%) $76.94
Gas
(4.75%) $2.71
Gold
(-0.08%) $2 343.90
Silver
(-0.10%) $30.41
Platinum
(0.46%) $1 046.80
USD/EUR
(0.02%) $0.921
USD/NOK
(0.02%) $10.49
USD/GBP
(-0.01%) $0.785
USD/RUB
(-0.44%) $90.04

Realtime updates for Aceto Corporation [ACET]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
Upcoming Earnings Alert

2 days till quarter result
(tns 2024-06-05)

Expected move: +/- 8.86%

BUY
62.50%
return 2.12%
SELL
22.22%
return 14.78%
Last Updated31 May 2024 @ 16:00

-2.03% $ 1.450

BUY 157488 min ago

@ $2.93

Issued: 14 Feb 2024 @ 15:42


Return: -50.43%


Previous signal: Feb 14 - 14:49


Previous signal: Sell


Return: -1.02 %

Live Chart Being Loaded With Signals

Commentary (31 May 2024 @ 16:00):

Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and enhance persistence for durable activity in patients...

Stats
Today's Volume 444 760
Average Volume 1.26M
Market Cap 119.15M
EPS $0 ( 2024-05-14 )
Next earnings date ( $-0.390 ) 2024-06-05
Last Dividend $0.0100 ( 2018-09-21 )
Next Dividend $0 ( N/A )
P/E -0.490
ATR14 $0.00600 (0.41%)
Insider Trading
Date Person Action Amount type
2024-01-25 Orbimed Advisors Llc Buy 1 841 100 Common Stock
2024-01-25 Orbimed Advisors Llc Buy 1 041 700 Common Stock
2024-01-25 Orbimed Advisors Llc Buy 242 200 Common Stock
2024-01-25 Gordon Carl L Buy 1 841 100 Common Stock
2024-01-25 Gordon Carl L Buy 1 041 700 Common Stock
INSIDER POWER
58.73
Last 100 transactions
Buy: 13 014 935 | Sell: 4 163 691

Volume Correlation

Long: 0.23 (neutral)
Short: 0.62 (weak)
Signal:(63.416) Neutral

Aceto Corporation Correlation

10 Most Positive Correlations
OZEM1
ENSC0.864
BBGI0.864
PEV0.863
TOI0.857
SYPR0.856
OPOF0.855
CNTG0.85
DRTS0.849
FXNC0.847
10 Most Negative Correlations
SSIC-0.878
VCTR-0.874
JAN-0.863
FRLA-0.856
MWFLX-0.847
BNTC-0.846
BNIX-0.846
PRIM-0.841
SLAM-0.841
CTRE-0.838

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Aceto Corporation Correlation - Currency/Commodity

The country flag -0.23
( neutral )
The country flag -0.25
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.35
( neutral )

Aceto Corporation Financials

Annual 2023
Revenue: $0
Gross Profit: $-6.10M (0.00 %)
EPS: $-3.31
FY 2023
Revenue: $0
Gross Profit: $-6.10M (0.00 %)
EPS: $-3.31
FY 2022
Revenue: $24.99M
Gross Profit: $19.98M (79.96 %)
EPS: $-1.630
FY 2021
Revenue: $9.73M
Gross Profit: $9.73M (100.00 %)
EPS: $-2.00

Financial Reports:

No articles found.

Aceto Corporation Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

Aceto Corporation Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 0.755 - low (50.00%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future
Information
First Dividend $0.100 2009-06-11
Last Dividend $0.0100 2018-09-21
Next Dividend $0 N/A
Payout Date 2018-10-09
Next Payout Date N/A
# dividends 32 --
Total Paid Out $2.12 --
Avg. Dividend % Per Year 0.00% --
Score 1.82 --
Div. Sustainability Score 0.755
Div.Growth Potential Score 0
Div. Directional Score 0 --
Next Divdend (Est)
(2024-08-01)
$0 Estimate 0.00 %
Dividend Stability
0.11 Bad
Dividend Score
1.82
Pay Frequency
Quarterly
Yearly Payout
Year Amount Yield
2009 $0 0.00%
2010 $0 0.00%
2011 $0 0.00%
2012 $0 0.00%
2013 $0 0.00%
2014 $0 0.00%
2015 $0 0.00%
2016 $0 0.00%
2017 $0 0.00%
2018 $0.0850 0.75%
2019 $0 0.00%
2020 $0 0.00%
2021 $0 0.00%
2022 $0 0.00%
2023 $0 0.00%
2024 $0 0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NASDAQ

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
OXSQ Dividend Royal 2023-12-14 Monthly 21 9.10% 8.50
GLDI Dividend Royal 2023-11-20 Monthly 12 7.15% 8.50
PSEC Dividend Royal 2023-12-26 Monthly 21 7.04% 8.50
QYLD Dividend Royal 2023-11-20 Monthly 11 7.50% 8.50
SLVO Dividend Royal 2023-11-20 Monthly 12 10.77% 8.50
OXLC Dividend Diamond 2023-12-14 Monthly 14 10.00% 8.50
GAIN Dividend Royal 2023-12-04 Monthly 20 8.19% 8.50
HRZN Dividend Royal 2023-12-18 Monthly 15 6.60% 8.45
USOI Dividend Royal 2023-11-20 Monthly 8 16.70% 8.28
PFLT Dividend King 2023-11-15 Monthly 14 6.50% 8.27

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM-10.841.500-10.00-10.00[0 - 0.5]
returnOnAssetsTTM-0.4771.200-10.00-10.00[0 - 0.3]
returnOnEquityTTM-0.6481.500-8.31-10.00[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM14.340.80010.008.00[1 - 3]
quickRatioTTM14.180.80010.008.00[0.8 - 2.5]
cashRatioTTM14.181.50010.0010.00[0.2 - 2]
debtRatioTTM0.0684-1.5008.86-10.00[0 - 0.6]
interestCoverageTTM3 561.641.00010.0010.00[3 - 30]
operatingCashFlowPerShareTTM-1.1692.00-0.390-0.780[0 - 30]
freeCashFlowPerShareTTM-1.2052.00-0.602-1.205[0 - 20]
debtEquityRatioTTM0.0774-1.5009.69-10.00[0 - 2.5]
grossProfitMarginTTM0.3821.0006.976.97[0.2 - 0.8]
operatingProfitMarginTTM-11.601.000-10.00-10.00[0.1 - 0.6]
cashFlowToDebtRatioTTM-4.621.000-10.00-10.00[0.2 - 2]
assetTurnoverTTM0.04400.800-3.04-2.43[0.5 - 2]
Total Score0.755

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM-0.8201.000-0.1840[1 - 100]
returnOnEquityTTM-0.6482.50-5.34-10.00[0.1 - 1.5]
freeCashFlowPerShareTTM-1.2052.00-0.402-1.205[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM-1.1692.00-0.390-0.780[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM-0.06041.500-3.740[0.5 - 2]
operatingCashFlowSalesRatioTTM-7.171.000-10.000[0.1 - 0.5]
Total Score-2.74

Aceto Corporation Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Aceto Corporation

Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and enhance persistence for durable activity in patients. Its lead product in pipeline includes ADI-001, which is in Phase I clinical study for the treatment of non-Hodgkin's lymphoma. The company also engages in the development of ADI-002, which is undergoing preclinical studies for the treatment of various solid tumors. Adicet Bio, Inc. is based in Boston, Massachusetts.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

Total Execution Time: 1.7521121501923 seconds
Number of API calls: 2
Number of DB calls: 8